Please ensure Javascript is enabled for purposes of website accessibility

Why Tilray Stock Is Plunging Today

By Prosper Junior Bakiny – Aug 11, 2020 at 3:32PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company released its second-quarter financial results.

What happened?

Shares of Tilray (TLRY) are down by 13.1% as of 3:22 p.m. EDT on Tuesday, following the company's release of its second-quarter earnings report after the market closed on Monday. Tilray has made it a habit to disappoint investors with its financial results, and the company's latest quarterly update was yet another example of this trend. 

So what

During the second quarter, Tilray reported total revenue of $50.4 million, about 10% higher than the prior-year quarter. On average, analysts expected the cannabis company's revenue to come in at about $55 million. One bright spot in the company's top-line breakdown was its international cannabis segment, whose sales grew by 349% year over year to $8.3 million. However, this segment still accounts for a small percentage of Tilray's total revenue. The company's bottom line was the biggest cause for concern, however. 

Red maple leaf surrounded by cannabis leaves.

Image source: Getty Images.

Tilray recorded a net loss of $81.7 million -- or $0.65 on a per-share basis -- compared to the net loss of $36.3 million (and the $0.37 net loss per share) it recorded during the second quarter of the previous fiscal year. On average, analysts were expecting Tilray's net loss per share to be $0.20, which means the company fell far short of expectations. Given these less than stellar results, it isn't surprising that investors are selling off shares of this cannabis stock today. 

Now what

Tilray's stock has not rebounded nearly as well as the broader market has since mid-March, and the company's stock is still down by 59.6% year to date. Given the precarious state of the economy, the volatile cannabis industry, and the fact that Tilray is still unprofitable, investors may want to steer clear of this company for now. 

Prosper Junior Bakiny has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Tilray Stock Quote

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/05/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.